ITOS
Price
$10.11
Change
-$0.00 (-0.00%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
446.57M
One day until earnings call
OCUL
Price
$12.49
Change
+$0.49 (+4.08%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
1.91B
96 days until earnings call
Interact to see
Advertisement

ITOS vs OCUL

Header iconITOS vs OCUL Comparison
Open Charts ITOS vs OCULBanner chart's image
iTeos Therapeutics
Price$10.11
Change-$0.00 (-0.00%)
Volume$26.72K
Capitalization446.57M
Ocular Therapeutix
Price$12.49
Change+$0.49 (+4.08%)
Volume$37.54K
Capitalization1.91B
ITOS vs OCUL Comparison Chart in %
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. OCUL commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a StrongBuy and OCUL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ITOS: $10.09 vs. OCUL: $11.92)
Brand notoriety: ITOS and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 102% vs. OCUL: 67%
Market capitalization -- ITOS: $446.57M vs. OCUL: $1.91B
ITOS [@Biotechnology] is valued at $446.57M. OCUL’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $96.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 3 bullish TA indicator(s).

  • ITOS’s TA Score: 4 bullish, 3 bearish.
  • OCUL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than OCUL.

Price Growth

ITOS (@Biotechnology) experienced а -0.79% price change this week, while OCUL (@Biotechnology) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +19.02%, and the average quarterly price growth was +14.26%.

Reported Earning Dates

ITOS is expected to report earnings on Aug 07, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.91B) has a higher market cap than ITOS($447M). OCUL YTD gains are higher at: 39.578 vs. ITOS (31.380). ITOS has higher annual earnings (EBITDA): -146.71M vs. OCUL (-176.35M). ITOS has more cash in the bank: 520M vs. OCUL (350M). ITOS has less debt than OCUL: ITOS (5.05M) vs OCUL (76.2M). OCUL has higher revenues than ITOS: OCUL (59.6M) vs ITOS (35M).
ITOSOCULITOS / OCUL
Capitalization447M1.91B23%
EBITDA-146.71M-176.35M83%
Gain YTD31.38039.57879%
P/E RatioN/AN/A-
Revenue35M59.6M59%
Total Cash520M350M149%
Total Debt5.05M76.2M7%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSOCUL
RSI
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 6 days ago
81%
Momentum
ODDS (%)
Bearish Trend 6 days ago
80%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 6 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
72%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
79%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
81%
Aroon
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WGLSX13.020.02
+0.15%
Wasatch Long/Short Alpha Institutional
PURRX19.68-0.01
-0.05%
PGIM Global Real Estate R
PJOQX22.56-0.27
-1.18%
PGIM Jennison Focused Value R6
ERSMX31.45-0.45
-1.41%
Eaton Vance Atlanta Capital SMID-Cap R
IEOSX15.83-0.33
-2.04%
Voya Large Cap Growth Port S

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-0.49%
BMRN - ITOS
49%
Loosely correlated
N/A
IBO - ITOS
45%
Loosely correlated
+0.57%
BDTX - ITOS
43%
Loosely correlated
-2.63%
IMNM - ITOS
41%
Loosely correlated
+0.67%
OCUL - ITOS
40%
Loosely correlated
+2.94%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+2.94%
EYPT - OCUL
64%
Loosely correlated
-1.12%
RVMD - OCUL
57%
Loosely correlated
-1.72%
IMVT - OCUL
56%
Loosely correlated
-5.48%
DNLI - OCUL
55%
Loosely correlated
-2.82%
IDYA - OCUL
55%
Loosely correlated
-0.33%
More